Tat Protein Induces Human Immunodeficiency Virus Type 1 (HIV-1) Coreceptors and Promotes Infection with both Macrophage-Tropic and T-Lymphotropic HIV-1 Strains
暂无分享,去创建一个
Irene Bosch | Joseph Sodroski | J. Sodroski | I. Bosch | A. Pardee | W. Hofmann | Arthur B. Pardee | Lili Huang | Lili Huang | Wolfgang Hofmann
[1] C. Broder,et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. , 1996, Science.
[2] G. Joø,et al. Macrophage tropism: fact or fiction? , 1997, Journal of leukocyte biology.
[3] G. Riethmüller,et al. LOSS OF CIRCULATING T4+ MONOCYTES IN PATIENTS INFECTED WITH HTLV-III , 1986, The Lancet.
[4] M. Previati,et al. Exogenous human immunodeficiency virus type‐1 Tat protein selectively stimulates a phosphatidylinositol‐specific phospholipase C nuclear pathway in the Jurkat T cell line , 1995, European journal of immunology.
[5] M. Negrini,et al. The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. , 1995, Blood.
[6] Hassan Mohammad Naif,et al. CCR5 Expression Correlates with Susceptibility of Maturing Monocytes to Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.
[7] Anthony S. Fauci,et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.
[8] R. Gentz,et al. Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[9] J J Goedert,et al. Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.
[10] A. Sica,et al. Bacterial Lipopolysaccharide Rapidly Inhibits Expression of C–C Chemokine Receptors in Human Monocytes , 1997, The Journal of experimental medicine.
[11] B. Chesebro,et al. Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[12] I. Hewlett,et al. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. , 1996, Journal of immunology.
[13] Nancy Sullivan,et al. CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro , 1997, The Journal of experimental medicine.
[14] M. Stevenson,et al. HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.
[15] K. Yamada,et al. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. , 1997, Journal of immunology.
[16] C. Van Lint,et al. Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway , 1997, Science.
[17] Marc Parmentier,et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.
[18] A. Pardee,et al. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] Ying Sun,et al. The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.
[20] I. Hewlett,et al. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. , 1996, Journal of immunology.
[21] J. Moore,et al. Chemoattractants attract HIV researchers , 1996, The Journal of experimental medicine.
[22] A. Trkola,et al. Co-receptors for HIV-1 entry. , 1997, Current opinion in immunology.
[23] R. Doms,et al. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains , 1996, Journal of virology.
[24] Virginia Litwin,et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.
[25] K. Jones,et al. Tat and the HIV-1 promoter. , 1993, Current opinion in cell biology.
[26] M. Baggiolini,et al. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes , 1996, The Journal of experimental medicine.
[27] S. Capitani,et al. Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes. , 1996, Journal of immunology.
[28] P. Wingfield,et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation , 1993, Journal of virology.
[29] J. Skowroński,et al. CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. Pardee,et al. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[31] P. Krammer,et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 , 1995, Nature.
[32] E. Engleman,et al. Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. , 1989, Journal of immunology.
[33] Ashley T. Haase,et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.
[34] C. Mackay,et al. Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes , 1998, The Journal of experimental medicine.
[35] V. Karsten,et al. HIV‐1 envelope glycoprotein gp120 down‐regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor‐α , 1996, Immunology.
[36] B. Levine,et al. Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells. , 1997, Science.
[37] Marc Parmentier,et al. A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.
[38] D. Mosier,et al. Macrophage-tropic HIV: critical for AIDS pathogenesis? , 1994, Immunology today.
[39] C. Ambrosino,et al. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein , 1994, The Journal of experimental medicine.
[40] J. Zack,et al. CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus , 1997, Journal of virology.
[41] J. Sodroski,et al. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants , 1990, Journal of virology.
[42] J. McCune. Viral latency in HIV disease , 1995, Cell.
[43] Jerome A. Zack,et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.
[44] V. Metelev,et al. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.
[45] C. Debouck,et al. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat , 1990, The Journal of cell biology.
[46] R. Gallo,et al. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[47] A. Frankel,et al. Endocytosis and targeting of exogenous HIV‐1 Tat protein. , 1991, The EMBO journal.
[48] L. Montaner,et al. Lipopolysaccharide (LPS) down‐regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor (TNF) and IL‐1β , 1995, Clinical and experimental immunology.
[49] Stephen C. Peiper,et al. Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.
[50] M. Baggiolini,et al. CCR5 is characteristic of Th1 lymphocytes , 1998, Nature.
[51] C. Broder,et al. CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.
[52] H. Sheppard,et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression , 1997, Nature Medicine.
[53] T. Luger,et al. Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes. , 1997, Journal of immunology.
[54] Luigi Buonaguro,et al. HIV‐1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix‐associated heparan sulfate proteoglycans through its basic region , 1997, AIDS.
[55] Paul E. Kennedy,et al. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.
[56] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.
[57] L. Buonaguro,et al. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines , 1992, Journal of virology.
[58] R. Doms,et al. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses , 1997, Journal of virology.
[59] C. Mackay,et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[60] Steven M. Wolinsky,et al. The role of a mutant CCR5 allele in HIV–1 transmission and disease progression , 1996, Nature Medicine.
[61] P. Krammer,et al. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells , 1994, Journal of virology.
[62] S. Krane,et al. Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes. , 1983, Journal of immunology.
[63] S. Capitani,et al. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[64] M. Lenburg,et al. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4 , 1993, Journal of virology.